Literature DB >> 25964511

Differential diagnosis at admission between Takotsubo cardiomyopathy and acute apical-anterior myocardial infarction in postmenopausal women.

Alessandro Zorzi1, Anna Baritussio1, Mohamed ElMaghawry2, Mariachiara Siciliano1, Federico Migliore1, Martina Perazzolo Marra1, Sabino Iliceto1, Domenico Corrado3.   

Abstract

BACKGROUND: Takotsubo cardiomyopathy (TTC) typically affects postmenopausal women and clinically presents with chest pain, ST-segment elevation, elevated cardiac enzymes and apical left ventricular (LV) wall motion abnormalities that mimic 'apical-anterior' acute myocardial infarction (AMI). This study assessed whether at-admission clinical evaluation helps in differential diagnosis between the two conditions.
METHODS: The study compared at-admission clinical, electrocardiographic (ECG) and echocardiographic findings of 31 women (median age 67 years, interquartile range (IQR) 62-76) with typical TTC and 30 women (median age 73 years, IQR 61-81) with apical-anterior AMI due to acute occlusion of the mid/distal left anterior descending coronary artery.
RESULTS: Women with TTC significantly more often showed PR-segment depression (62% versus 3%, p<0.001), J-waves (26% versus 3%, p=0.03), maximum ST-segment elevation ⩽2 mm (84% versus 37%, p<0.001) and ST-segment elevation in lead II (42% versus 10%, p=0.01) than those with AMI. At multivariate analysis, PR-segment depression (odds ratio (OR)=37.2, 95% confidence interval (CI)=3.4-424, p=0.002) and maximum ST-segment elevation ⩽2 mm (OR=11.1, 95% CI=1.7-99.4, p=0.01) remained the only independent predictors of TTC and the co-existence of both parameters excluded AMI with a 100% specificity. The two groups did not differ with regard to age, first troponin-I value, echocardiographic LV ejection fraction and distribution of hypo/akinetic LV segments.
CONCLUSIONS: At-admission electrocardiogram (but no clinical, laboratory and echocardiographic features) allows differential diagnosis between TTC and apical-anterior AMI in postmenopausal women. The combination of PR-segment depression and mild (⩽2 mm) ST-segment elevation predicted TTC with greater accuracy than traditional parameters such as localisation of ST-segment elevation and reciprocal ST-segment depression. © The European Society of Cardiology 2015.

Entities:  

Keywords:  Electrocardiogram; PR-segment depression; acute coronary syndrome; apical ballooning; gender medicine; myocardial infarction; pericarditis; troponin

Mesh:

Year:  2015        PMID: 25964511     DOI: 10.1177/2048872615585515

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  4 in total

1.  ECG differences and ECG predictors in patients presenting with ST segment elevation due to myocardial infarction versus takotsubo syndrome.

Authors:  Rickard Zeijlon; Jasmina Chamat; Vina Le; Johan Wågerman; Israa Enabtawi; Sandeep Jha; Mohammed Munir Mohammed; Aaron Shekka Espinosa; Oskar Angerås; Truls Råmunddal; Elmir Omerovic; Björn Redfors
Journal:  Int J Cardiol Heart Vasc       Date:  2022-05-06

2.  Clinical Characteristics and Long-Term Mortality Rate in Female Patients with Takotsubo Syndrome Compared with Female Patients with ST-Elevation Acute Myocardial Infarction: A Retrospective Study from a Single Center.

Authors:  Laura Massobrio; Alberto Valbusa; Marina Sartini; Giovanni Meliota; Francesca Cavalla; Roberta Miceli; Giulia Vischi; Maria Luisa Cristina; Anna Maria Spagnolo; Roberto Delfino; Francesco Abbadessa; Italo Porto; Claudio Brunelli; Gian Marco Rosa
Journal:  Cardiol Res Pract       Date:  2019-07-30       Impact factor: 1.866

Review 3.  Takotsubo Syndrome and COVID-19: Associations and Implications.

Authors:  Rohan M Shah; Morish Shah; Sareena Shah; Angela Li; Sandeep Jauhar
Journal:  Curr Probl Cardiol       Date:  2020-12-11       Impact factor: 5.200

4.  Takotsubo cardiomyopathy: A potentially serious trap (Data from the International Takotsubo Cardiomyopathy Registry).

Authors:  Kerolos Wagdy; Mohamed ElMaghawry
Journal:  Glob Cardiol Sci Pract       Date:  2015-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.